𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rituximab plus CHOP improves outcomes in elderly with follicular lymphoma

Book ID
118627788
Publisher
Frontline Medical Communications, Inc.
Year
2007
Tongue
English
Weight
47 KB
Volume
4
Category
Article
ISSN
1548-5315

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

CHOP Chemotherapy plus Rituximab Compare
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
✍ Coiffier, Bertrand; Lepage, Eric; BriΓ¨re, Josette; Herbrecht, Raoul; Tilly, Herv πŸ“‚ Article πŸ“… 2002 πŸ› Massachusetts Medical Society 🌐 English βš– 116 KB

## Background The standard treatment for patients with diffuse large-B-cell lymphoma is cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP). Rituximab, a chimeric monoclonal antibody against the CD20 B-cell antigen, has therapeutic activity in diffuse large-B-cell lymphoma. We conduct